Title: Telemonitoring for Heart Failure Evidence
1Telemonitoring for Heart FailureEvidence
Practice
- Professor John G.F. Cleland
- Department of Cardiology,
- Hull York Medical SchoolUniversity of Hull
- Kingston-upon-Hull
- UK
Conflict of Interest I have received honoraria
and/or research support from Philips, Bosch, GE,
Alere and St Jude
2Survival of Patients with a Primary Discharge
Diagnosis of Heart Failure England Wales
2009-2010
About 1 million people affected in the
UK 450,000 admissions per year (65,000 in first
diagnostic position) N 19,240 (about 30 of
all expected cases) Median age 79 years lt65 years
3,000 65-75 years 4,000 75-85 years
7,000 gt85 years 5,000
Cleland et al HEART 2011
3TeleHealthWhy is it Likely to Become Essential?
- More patients with long-term conditions
- More older people
- Longer survival with illness
- Better primary secondary prevention
- Fewer professionals to provide health-care
- Smaller proportion of population of working age
- Loss of migrant workforce as economies rival UK
- Better paid or more attractive / less stressful
jobs - More monitoring required
- Higher expected standards of care
- More treatments that need to be monitored
- More things that can be monitored
4TeleHealthWhy is it Likely to Become Essential?
- Patient preference Convenience
- Patients, Carers, Staff
- Reduced Costs
- Buildings, Staff, Transport
- Environmental impact
- Transport
- Parking
- Buildings
- Better record keeping !!!!!!!!!!!!!!!!!!!!!!!
5The Opportunity of Chronic Illness
- Most patients soon learn routines
- Or have relatives / friends that do
- Most patients are interested in maintaining or
improving their health - Patients are an inexpensive but neglected
health-care provider opportunity - Invest in patients
- Education
- Active Partnership
- Empowerment
6TeleHealth - What Might it Achieve?
Ultimate Intermediate
7TEN-HMSThe Trans-European NetworkHome-Care
Management SystemPatients about to be discharged
from hospital after an exacerbation of chronic
heart failure
54 of Patients Aged gt70 years
(Published JACC 2005)
8TEN-HMS
Reduction in Mortality NTS or HTM v UC Absolute
16.4 Relative 36
Mortality
No reduction in hospitalisation Shortening of
hospital stay with HTM
p lt 0,05
Cleland et al JACC 2005
9TEN-HMS
How do you feel about your health since
receiving Telemonitoring?
much safer
no change
much more anxious
safer
more anxious
Undef.
10TEN-HMS
Achieving Therapeutic Target
Patient Clinical Status
240 Days
120 Days
240 Days
differences between HTM and other groups. No
difference between UC and NTS
11TEN-HMS Total Patient Contacts
Contacts Per 1,000 Days Alive and Out of Hospital
Plt0.01 HTM v NTS
under-reporting of events likely in this group
12Structured Telephone Supportn 5,563(Cochrane
Review)
Mortality
HR 0.88 (0.76-1.01) p0.08
Inglis et al 2010
13Home Telemonitoringn 2,710 (Cochrane Review)
- New Trials
- TIM-HF
- COMPASS
- CHAMPION
- SENSE-HF
Mortality
HR 0.66 (0.54-0.87) plt0.0001
Inglis et al 2010
14Major Problems with RCTs of Service Delivery
- Technology differs
- Telephone Support including Voice Activated
Systems - Physiological telemonitoring
- Implanted or Not
- Care usually improves if it is the focus of
attention - Effect in control group
- Beware before v after comparisons
- Lack of integration into existing services
- Puts innovative interventions at a disadvantage
- Selection of patients at low risk with modern
treatment
15Percent of Days Lost To Hospitalisation or Death
TEHAF (12 months)
TEN-HMS (15 months)
TIM-HF (26 months)
8.9 8.4
37.0 21.3 22.6
4.5 6.1
16What Have We Done for TeleHealth in Hull?
- Established
- International reference site (LifeLab) for HF
epidemiology research - International reputation for research excellence
in telehealth - A model telehealth service
- Grants
- TEN-HMS
- Four FP7 grants relating to telehealth heart
failure - EDRF
- Industry Partnerships
- Philips, GE, Bosch, Cardiomems, St Jude others
- Publications
- gt500 PubMed citations in related fields
- TEN-HMS, Concept Papers, Editorials
- Systematic Reviews (EJHF, BMJ Cochrane)
- Inventions
- Dynamic risk analysis
- Complex management algorithms
17The Hull Model for TeleHealth
- HeartCycle
- Heart Failure
- Post-MI Rehab
Device Implant
Non-Invasive Home Monitoring
Community TeleKiosks Screening Long-Term
Conditions
18Services for Patients with Heart FailureThe
Kingston-upon-Hull Model
Heart Failure Discharge Nurse
Heart Failure Telemonitoring Nurse
Voluntary Patient-Support Organisations
Community Heart Failure Specialist Nurses
Patients in Hospital
Patients at Home
Family Doctor (NT-proBNP)
Specialist Clinics
19(No Transcript)
20Where Next?
- Interactive TV
- New monitoring technologies
- Implanted devices
- More intelligent use of the patient data
- Investing in patients as health-care providers
Centre for Telehealth
21The Hull Heart Failure Life-Lab30,000
patient-years of follow-upLargest, Longest
Follow-up, Epidemiologically-Representative
Cohort of Heart Failure in the WorldRich in
phenotyping, serial biomarker and outcome data
22HeartCycle Programme
- Shift from crisis detection to health maintenance
- Health Maintenance Envelope
- More optimistic
- Better way to engage/motivate patients
- More active management
- More activity likely to hold actors attention
- Clinical calibration
- Addresses the issue of false alerts
- Personalised Careplan
- Treatments
- Ideal monitoring envelope
23Motivation feedback on measures and trends, what
they mean and what to do about them Education
on healthy lifestyle, reasons for treatments,
self management
Health-Care Provider
Secondary Loop
Patient / Carer
Analysis
Primary Loop 70 of Care Decisions
Monitor
Intelligent, integrated, multi-measure (time
type) personalised analysis
Communication System
24Opportunities for TeleHealth
- Change in Philosophy
- Investment in patients (rather than experts)
- Patients as first and possibly main tier of
healthcare - Communication
- Patient, community health social services,
specialists - Common health record
- Checked (at least in part) by the patient
themselves - Decision support analysis
- Patient professional support
- Research potential
- Healthcare innovation
- Pharmaceutical industry especially
- Route to faster (ethical) adoption
- Convenience Preference
- Patient, Carer, Health Professional
- Environmental impact
25Conclusion
- The first era of telemonitoring is over
- Time to move from
- Crisis Detection
- to
- Health Maintenance
26(No Transcript)